BF Biosciences enters contract manufacturing deal with Lucky Core Industries D_Trends
BF Biosciences Limited (BFBL), a subsidiary of Ferozsons Laboratories Limited, has signed a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI). The agreement involves the production of two pharmaceutical products: Esopase IV 40 mg and Etipro IV 40 mg. This development was communicated by Ferozsons Laboratories in accordance with Section 96 of … Read more